References
- Kjærbye-Thygesen A, Huusom LD, Frederiksen K, Kjaer SK. Ovarian cancer in Denmark 1978–2002. Acta Obstet Gynecol Scand. 84; 2005: 1006–12
- Bertelsen K. Tumor reduction surgery and long-term survival in advanced ovarian cancer: a DACOVA study. Gynecol Oncol. 1990; 38: 203–9
- Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during platinum era. J Clin Oncol. 2002; 20: 1248–59
- Giede KC, Kieser K, Dodge J, Rosen B. Who should operate patients with ovarian cancer? An evidence-based review. Gynecol Oncol. 2005; 99: 447–61
- Engelen MJA, Kos HE, Willemse PHB, Aalders JG, Vries EGE, Schaapveld M, et al. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer. 2006; 106: 589–98
- Earle CC, Schrag D, Neville BA, Yabroff R, Topor M, Fahey A, et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst. 2006; 98: 172–80
- Schrag D, Earle C, Xu F, Panageas KS, Yabroff R, Bristow RE, et al. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J Natl Cancer Inst. 2006; 98: 163–71
- Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope CR, Wilson TO, et al. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol. 2006; 107: 77–85
- Kundel HL, Polansky M. Measurement of observer agreement. Radiology. 2003; 228: 303–8
- Paetsch I, Jahnke C, Ferrari VA, Rademarkers FE, Pellikka PA, Hundley WG, et al. Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging. Eur Heart J. 2006; 27: 1459–64
- www.figo.org/content/PDF/staging-booklet.pdf.
- Andersen ES, Knudsen AA, Svarrer T, Lund B, Nielsen K, Grove A, et al. The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Gynecol Oncol. 2005; 99: 552–6
- Marx CI, Moller C, Bendixen A, Kehlet H, Ottesen BS. Ovarie kræft I Danmark. Status for den kirurgiske indsats. [Ovarian cancer in Denmark. Status of the surgical intervention](in Danish with English abstract). Ugeskr Laeger. 2006; 168: 1537–40
- Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advance stage ovarian cancer. Gynecol Oncol. 2006; 100: 283–7
- Kumpulainen S, Kuoppala T, Leminen A, Penttinen J, Puistola U, Pukkala E, et al. Surgical treatment of ovarian cancer in different hospital categories – a prospective nation-wide study in Finland. Eur J Cancer. 2006; 42: 388–95
- Paulsen T, Kjærheim K, Kærn J, Tretli S, Trope C. Improved short-term survival for advanced ovarian, tubar, and peritoneal cancer patients operated at teaching hospitals. Int J Gynecol Cancer. 2006; 16s1: 11–7
- Tingulstad S, Skjeldestad FE, Hagen B. The effect of centralization of primary surgery on survival in ovarian cancer patients. Obstet Gynecol. 2003; 102: 499–5
- Tetsche MS, Nørgaard M, Skriver MV, Andersen ES, Lash TL, Sørensen HT. Accuracy of ovarian cancer ICD-10 diagnosis in a Danish population-based hospital discharge registry. Eur J Gynaecol Oncol. 2005; 6: 266–70